Developing a Plan to Evaluate Delivery of Health Care Treatments and Services for Duchenne Muscular Dystrophy (DMD)

Post Date

April 5th 2012

Application Due Date

June 4th 2012

Funding Opportunity Number

CDC-RFA-DD12-1208

CFDA Number(s)

93.184

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

3

Eligibility Categories

Unrestricted

Funding

• Estimated Total Funding:

  $150000

• Award Range:

  $0 - $150000

Grant Description

The purpose of this program is to provide support through a CDC cooperative agreement for non-research activities to develop a plan for evaluating whether health care treatments and services for people who have Duchenne muscular dystrophy are currently being delivered according to recommendations outlined in the DMD Care Considerations

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  Centers for Disease Control and Prevention (CDC)
  Procurement and Grants Office (PGO)
  Technical Information and Management Section (TIMS)
  Phone 770-488-2700

• Agency Mailing Address:

  General Submissin Inquries

• Agency Email Address:

  pgotim@cdc.gov

• More Information:

  NO LINK; PLEASE CLICK ON FULL ANNOUNCEMENT TAB AT THE TOP OF THIS PAGE